The Evaluation of Novel Diagnostics for Childhood Tuberculosis (END Childhood TB) study is a collaboration between the University of California, San Francisco (UCSF), USA, and Makerere University and Mulago National Referral Hospital in Kampala, Uganda to evaluate novel point-of-care tests and identify biomarkers for the diagnosis of TB in children. The study is funded by the U.S. National Institutes of Health.
« BackPosted on 21 September 2022 under Contributors, Contributors
© 2024 The Union. All Rights Reserved.
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |